These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 38454419)

  • 1. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
    Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
    J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
    Gao W; Wang X; Zhou Y; Wang X; Yu Y
    Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
    Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
    J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
    Niu X; Chen L; Li Y; Hu Z; He F
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):273-285. PubMed ID: 35288298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy.
    Catanzaro E; Feron O; Skirtach AG; Krysko DV
    Front Immunol; 2022; 13():925290. PubMed ID: 35844506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
    Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
    Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The applications of nanozymes in cancer therapy: based on regulating pyroptosis, ferroptosis and autophagy of tumor cells.
    Zhang Y; Yu W; Chen M; Zhang B; Zhang L; Li P
    Nanoscale; 2023 Jul; 15(29):12137-12156. PubMed ID: 37377098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
    Woo Y; Lee HJ; Jung YM; Jung YJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelation between Programmed Cell Death and Immunogenic Cell Death: Take Antitumor Nanodrug as an Example.
    Meng Q; Ding B; Ma P; Lin J
    Small Methods; 2023 May; 7(5):e2201406. PubMed ID: 36707416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
    Qi J; Jin F; Xu X; Du Y
    Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review).
    Liu RJ; Yu XD; Yan SS; Guo ZW; Zao XB; Zhang YS
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity.
    Li Y; Guo Y; Zhang K; Zhu R; Chen X; Zhang Z; Yang W
    Adv Sci (Weinh); 2024 Jan; 11(3):e2306580. PubMed ID: 37984863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
    Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
    J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy.
    Zhang L; Song A; Yang QC; Li SJ; Wang S; Wan SC; Sun J; Kwok RTK; Lam JWY; Deng H; Tang BZ; Sun ZJ
    Nat Commun; 2023 Sep; 14(1):5355. PubMed ID: 37660063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy.
    Hiep Tran T; Thu Phuong Tran T
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113085. PubMed ID: 39276455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment.
    Wan S; Zhang G; Liu R; Abbas MN; Cui H
    Cell Commun Signal; 2023 May; 21(1):115. PubMed ID: 37208730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supramolecularly Engineered Conjugate of Bacteria and Cell Membrane-Coated Magnetic Nanoparticles for Enhanced Ferroptosis and Immunotherapy of Tumors.
    Xie B; Zhao H; Ding YF; Wang Z; Gao C; Li S; Zhang K; Ip SW; Yu H; Wang R
    Adv Sci (Weinh); 2023 Dec; 10(34):e2304407. PubMed ID: 37850572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic cell death in cancer immunotherapy.
    Choi M; Shin J; Lee CE; Chung JY; Kim M; Yan X; Yang WH; Cha JH
    BMB Rep; 2023 May; 56(5):275-286. PubMed ID: 37081756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
    Garg AD; Agostinis P
    Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.